Company

Apollo Neuroscience

Wearable stress-relief device using silent touch therapy (vibrations) to improve heart rate variability, sleep, and focus.

Track Apollo Neuroscience

Founded: 2020
HQ: Los Angeles, CA, USA
Status: private

The verified answer

As of Sep 2026, DEPLOY verifies Apollo Neuroscience: $20.0M raised. 2 sources back the record.

Funding

$20.0M

Deploy Watch

Track Apollo Neuroscience on Deploy.

We notify you when a verified state change lands on the record, not when the company issues a claim.

Track Apollo Neuroscience

Regional ecosystem

Apollo Neuroscience is one of 433 verified robotics companies in California →

Valuation of record

DEPLOY VERIFIED

$90M (reported, approximate)as of Jan 2022

Priced roundSeries A post-money

See the full valuations ranking →

Key facts

Founded

2020, Pittsburgh, Pennsylvania

Founders

David Rabin MD PhD (Chief Innovation Officer), Greg Siegle PhD (Chief Scientific Officer)

Product

Apollo Neuro - wearable touch therapy device delivering low-frequency vibration patterns to improve sleep, stress resilience, and focus

Fundingsee investors →

Seed $5M; Series A $15M; total ~$20M

Science

Based on Dr. Rabin research at University of Pittsburgh on touch therapy for PTSD and stress; clinically tested HRV improvement

Differentiation

Vibroacoustic touch therapy rather than tracking; active intervention device; psychiatric research foundation

Data & sources

News coverage

Web sources

2 sources backing this record.View all →

Current leadership (2)

David Rabin MD PhD foundersecondary-verified
Greg Siegle PhD foundersecondary-verified

Founders (2)

Greg Siegle PhDcofounderno longer at company
David Rabin MD PhDcofounderno longer at company

See all founders across the registry →

Safety record

No incidents on record for Apollo Neuroscience.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Recent coverage

Apollo Neuroscience in third-party press

Innovation Awards Finalists Announced for SXSW 2020 - SXSW

Nov 17, 2025

Aqoon is-weydaarsiga: Horudhac SNOMED CT, Isbitaalada Apollo - Apollo Hospitals

Nov 4, 2015

Financial state

Total funding: $20.0M
Reporting basis: aggregator_estimate
Lifecycle stage: growth
Counterparty risk class: moderate

Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Funding rounds (2)

Funding by round

Apollo Neuroscience’s 2 disclosed rounds, $20M in total, oldest to newest.

Seed2020-01$5M

Series A2022-01$15M

Series A2022-01-01
$15M(reported) · $90M post
Seed2020-01-01
$5M(reported) · $20M post

See the full valuations ranking →

Timeline

Every recorded move in Apollo Neuroscience’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.

Funding roundSeries A funding round
2022-01-01
Series A raising $15000000
Funding roundSeed funding round
2020-01-01
Seed raising $5000000

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Record createdJun 7, 2026
Added to the verified registry

Full change history →

Sources (2)

Common questions

What is Apollo Neuroscience?

Wearable stress-relief device using silent touch therapy (vibrations) to improve heart rate variability, sleep, and focus. FDA-registered general wellness device.

What does Apollo Neuroscience make?

Apollo Neuroscience has no robot models recorded on the DEPLOY registry. Apollo Neuroscience builds robot foundation models or autonomy software.

Is Apollo Neuroscience publicly traded?

No. Apollo Neuroscience is privately held and not publicly traded, per the DEPLOY registry.

Who is the CEO of Apollo Neuroscience?

David Rabin MD PhD is the founder of Apollo Neuroscience, per the DEPLOY registry.

How can I invest in Apollo Neuroscience?

Apollo Neuroscience is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today. It has raised $20M in disclosed funding.

Where is Apollo Neuroscience headquartered?

Apollo Neuroscience is headquartered in Los Angeles, CA, USA.

How much funding has Apollo Neuroscience raised?

Apollo Neuroscience has raised approximately $20M in disclosed funding on record in the DEPLOY registry.

Who owns Apollo Neuroscience?

Apollo Neuroscience is privately held and venture-backed ($20M raised); ownership sits with its founders and private investors.

Is Apollo Neuroscience a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Apollo Neuroscience ranks in roughly the top 12% of companies tracked by the registry.

When was Apollo Neuroscience founded?

Apollo Neuroscience was founded in 2020.

Is Apollo Neuroscience safe?

Apollo Neuroscience has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Methodology: Verified · 2 sources (no primary) · last reviewed 2026-08-21

Verification posture

Verified

Medium confidence

Review state

Stable

Last reviewed 2026-08-21

Sources by quality tier

1: unclassified; Unclassified source
1: secondary-established-publication; Established publication

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.